Artificial Intelligence
Global Life Science Tools Market to Reach $258.6 Billion by 2030
<!– Name:DistributionId Value:8749873 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:5557 –> <!– Name:CustomerId Value:1199811 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:4fa8abc4-56cb-4eab-83eb-b7183c6922ed –>
New York, Feb. 15, 2023 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Life Science Tools Industry” – https://www.reportlinker.com/p06032055/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Life Science Tools Market to Reach $258.6 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Life Science Tools estimated at US$133 Billion in the year 2022, is projected to reach a revised size of US$258.6 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2022-2030. Cell Biology, one of the segments analyzed in the report, is projected to record a 7.8% CAGR and reach US$82.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Genomics segment is readjusted to a revised 8.9% CAGR for the next 8-year period.
The U.S. Market is Estimated at $48.4 Billion, While China is Forecast to Grow at 13% CAGR
The Life Science Tools market in the U.S. is estimated at US$48.4 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$31.1 Billion by the year 2030 trailing a CAGR of 13% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.3% and 8.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.
Select Competitors (Total 295 Featured)
– Abbott Laboratories Inc.
– Agilent Technologies, Inc.
– Becton, Dickinson and Company
– Bio-Rad Laboratories, Inc.
– Bruker Corporation
– Carl Zeiss AG
– Eppendorf SE
– F. Hoffmann-La Roche AG
– Hitachi High-Tech Corporation
– Illumina, Inc.
– Merck KGaA
– Oxford Instruments plc
– PerkinElmer Inc.
– QIAGEN N.V.
– Shimadzu Corporation
– Thermo Fisher Scientific Inc.
Read the full report: https://www.reportlinker.com/p06032055/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
A Prelude to Life Sciences Tools
Impact of Covid-19 and Global Economic Update
War & Inflation Supersede COVID-19 as Major Downside Risks for
the Global Economy in 2023 & Beyond
Here?s How Inflationary Pressures Affect the Economy
Russia-Ukraine War, the Primary Culprit Responsible for the
Hardships
Stubbornly High Inflation to Single Handedly Drag Down Global
Growth
Here?s What?s Causing the Current Spike in Inflation
EXHIBIT 1: War-Induced Commodity Price Increases & Broad Based
Price Pressures Mark the Return of Global Inflation in 2022 to
the Highest Level Seen Since 1996: Global Inflation Rates (In
%) for the Years 2019 Through 2024
EXHIBIT 2: War, Global Inflation, Cost of Living Crisis, Failed
Fiscal Policy Attempts to Restore Price Stability & Contain
Downside Risks to Result in Sharper-Than-Expected Slowdown in
Global Economic Growth: World Economic Growth Projections:
(Real GDP, Annual % Change) for the Years 2020, 2021, 2022
and 2023
EXHIBIT 3: Recession Triggered by Uncontrolled Inflation or
Unemployment, Which is the Greater Evil? Inflation Battling
Policy Measures to Slowdown Post Pandemic Recovery in
Unemployment Rates: Global Number of Unemployed People (In
Million) for Years 2019 Through 2023
EXHIBIT 4: Year Unemployed People (In Million) 2017, 2018,
2019, 2020, 2021, 2022 & 2023
Life Science Tools Market Gains Precedence during COVID-19
Pandemic
Competition
Players Pursue Product Launch & Innovation to Stay Relevant in
Competitive Life Science Tools Market
EXHIBIT 5: Life Science Tools – Global Key Competitors
Percentage Market Share in 2023 (E)
Competitive Market Presence – Strong/Active/Niche/Trivial for
308 Players Worldwide in 2023 (E)
Global Market Analysis and Prospects
Global Life Science Tools Market Appears Primed for Healthy
Growth Ahead
Cell Biology Holds Significant Revenue Stake
Hospitals Remain Primary End-User Segment
North America Maintains Front Rank in Global Life Science Tools
Market
Asia-Pacific to Exhibit Impressive Growth
Salient Drivers Keeping Global Life Science Tools Market in
Good Shape
Technology Trends in the Life Sciences Domain
Connected Devices, IoT Ecosystems to Transform the Life Science
Landscape
Exponential Intelligence, Quantum Computing and Ambient
Technologies to Make Headway
Cloud Platforms Ease Data Sharing
Life Sciences to Gain with Blockchain Edge
AI-enabled Automation to Deliver Tangible Benefits for All
Cybersecurity Needs Grow for Life Sciences
Intertwined Factors with Major Implications for Life Science
Domain & Related Tools
Recent Market Activity
World Brands
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Trends in Life Science Sector Support Demand
Why Diagnostic Testing is Key to Mitigate Impact of Infectious
Diseases?
3D Cell Culture Transforms Life Sciences Industry
EXHIBIT 6: Global 3D Cell Culture Market in US$ Million: 2020 –
2027
Increasing Demand for 3D Cell Culture in Drug Discovery
Use of 3D Cell Culture for Regenerative Medicine
Proteomics Emerges as an Important Research Tool in Battle
against COVID-19
Proteomics Profiling to Expedite Drug Discovery
Proteomics at the Fore with Latest Advances
Mass Spectrometry (MS) Expands Application of Proteomics
AI and Machine Learning Address Shortcomings of Traditional
Equipment in Effectively Identifying Protein Patterns
mRNA Technology Gains Spotlight in Life Sciences
Innovations in Instrumentation Expand Functionality and Drive
Adoption of PCR
Synoptic Review of Quantitative PCR Technical Advancements in
the Recent Years
EXHIBIT 7: Global qPCR and dPCR Instrumentation Market in US$
Million: 2020-2025
Genome Sequencing Experiences Host of Evolutionary Waves
Greater Integration of Genomic Technologies in the Development
of Novel Diagnostics Tests
Next Generation Sequencing Drives the Market Growth
R&D Activity Remains Vibrant in NGS
The Need for Large-scale NGS Data Analysis Pushes for Cloud-
enabled Bioinformatics Services
Single-Cell Spatial Biology Technologies Poised to Emerge as an
Integral Aspect of Future Labs
Rising Application of Whole Genome Sequencing Drives Demand for
Faster Secondary Analysis Tools
Rapid Growth in Biopharma Industry and Rising Investments in R
&D to Boost Market Prospects
EXHIBIT 8: Global BioPharmaceuticals Market in US$ Billion:
2020 and 2026
Liquid Chromatography Drives Growth in New Application Markets
Innovative HPLC Products Inject New Growth
Digital Transformation of Life Sciences Sector Improves
Efficiency and Productivity
EXHIBIT 9: Key Initiators of Digital Transformation in Life
Sciences
Artificial Intelligence offers Multiple Opportunities
Wearable Devices Gains Popularity
The Cloud Technology Witnesses Rapid Growth
VR and E-pharmacy
Smart Quality
Growing R&D Spending in Pharma and Biotechnology Sectors
Presents Opportunities
EXHIBIT 10: Pharmaceutical R&D Spending Worldwide (USD Billion)
for 2015-2025
Technological Developments and Expanding End-Use Applications
to Bolster Growth in Mass Spectrometry
EXHIBIT 11: Global Chromatography Market (2022): Percentage
Share Breakdown of Value Sales by Chromatography Techniques
Miniature Mass Spectroscopy Instruments Get Popular
Increase in Healthcare Spending to Propel Demand for Life
Science Tools
EXHIBIT 12: World Healthcare Expenditure (In US$ Billion) for
the Years 2017-2023
The Rise of Data Analytics in Life Sciences
Data Science in Drug R&D
Data Sharing Emerges as a Significant Trend to Gain Competitive
Advantage
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Life Science Tools Market Analysis of Annual
Sales in US$ Million for Years 2014 through 2030
Table 2: World Recent Past, Current & Future Analysis for Life
Science Tools by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Revenues in US$
Million for Years 2022 through 2030 and % CAGR
Table 3: World Historic Review for Life Science Tools by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Revenues in US$ Million for
Years 2014 through 2021 and % CAGR
Table 4: World 16-Year Perspective for Life Science Tools by
Geographic Region – Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2014, 2023 & 2030
Table 5: World Recent Past, Current & Future Analysis for Cell
Biology by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Revenues in US$
Million for Years 2022 through 2030 and % CAGR
Table 6: World Historic Review for Cell Biology by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Revenues in US$ Million for Years 2014 through 2021
and % CAGR
Table 7: World 16-Year Perspective for Cell Biology by
Geographic Region – Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 8: World Recent Past, Current & Future Analysis for
Genomics by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Revenues in US$
Million for Years 2022 through 2030 and % CAGR
Table 9: World Historic Review for Genomics by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Revenues in US$ Million for Years 2014 through 2021
and % CAGR
Table 10: World 16-Year Perspective for Genomics by Geographic
Region – Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 11: World Recent Past, Current & Future Analysis for
Proteomics by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Revenues in US$
Million for Years 2022 through 2030 and % CAGR
Table 12: World Historic Review for Proteomics by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Revenues in US$ Million for Years 2014 through 2021
and % CAGR
Table 13: World 16-Year Perspective for Proteomics by
Geographic Region – Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 14: World Recent Past, Current & Future Analysis for
Other Technologies by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Revenues in US$
Million for Years 2022 through 2030 and % CAGR
Table 15: World Historic Review for Other Technologies by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Revenues in US$ Million for
Years 2014 through 2021 and % CAGR
Table 16: World 16-Year Perspective for Other Technologies by
Geographic Region – Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 17: World Recent Past, Current & Future Analysis for
Healthcare by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Revenues in US$
Million for Years 2022 through 2030 and % CAGR
Table 18: World Historic Review for Healthcare by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Revenues in US$ Million for Years 2014 through 2021
and % CAGR
Table 19: World 16-Year Perspective for Healthcare by
Geographic Region – Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 20: World Recent Past, Current & Future Analysis for
Biopharmaceutical Companies by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets – Independent Analysis of Annual Revenues in
US$ Million for Years 2022 through 2030 and % CAGR
Table 21: World Historic Review for Biopharmaceutical Companies
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Revenues in US$ Million for
Years 2014 through 2021 and % CAGR
Table 22: World 16-Year Perspective for Biopharmaceutical
Companies by Geographic Region – Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030
Table 23: World Recent Past, Current & Future Analysis for
Government & Academics by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets – Independent Analysis of Annual Revenues in
US$ Million for Years 2022 through 2030 and % CAGR
Table 24: World Historic Review for Government & Academics by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Revenues in US$ Million for
Years 2014 through 2021 and % CAGR
Table 25: World 16-Year Perspective for Government & Academics
by Geographic Region – Percentage Breakdown of Value Revenues
for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa for Years 2014, 2023 & 2030
Table 26: World Recent Past, Current & Future Analysis for
Other End-Uses by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Revenues in US$
Million for Years 2022 through 2030 and % CAGR
Table 27: World Historic Review for Other End-Uses by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Revenues in US$ Million for
Years 2014 through 2021 and % CAGR
Table 28: World 16-Year Perspective for Other End-Uses by
Geographic Region – Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
Life Science Tools Market Presence – Strong/Active/Niche/
Trivial – Key Competitors in the United States for 2023 (E)
Market Analytics
Table 29: USA Recent Past, Current & Future Analysis for Life
Science Tools by Technology – Cell Biology, Genomics,
Proteomics and Other Technologies – Independent Analysis of
Annual Revenues in US$ Million for the Years 2022 through 2030
and % CAGR
Table 30: USA Historic Review for Life Science Tools by
Technology – Cell Biology, Genomics, Proteomics and Other
Technologies Markets – Independent Analysis of Annual Revenues
in US$ Million for Years 2014 through 2021 and % CAGR
Table 31: USA 16-Year Perspective for Life Science Tools by
Technology – Percentage Breakdown of Value Revenues for Cell
Biology, Genomics, Proteomics and Other Technologies for the
Years 2014, 2023 & 2030
Table 32: USA Recent Past, Current & Future Analysis for Life
Science Tools by End-Use – Healthcare, Biopharmaceutical
Companies, Government & Academics and Other End-Uses –
Independent Analysis of Annual Revenues in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 33: USA Historic Review for Life Science Tools by End-Use –
Healthcare, Biopharmaceutical Companies, Government &
Academics and Other End-Uses Markets – Independent Analysis of
Annual Revenues in US$ Million for Years 2014 through 2021 and
% CAGR
Table 34: USA 16-Year Perspective for Life Science Tools by
End-Use – Percentage Breakdown of Value Revenues for
Healthcare, Biopharmaceutical Companies, Government & Academics
and Other End-Uses for the Years 2014, 2023 & 2030
CANADA
Table 35: Canada Recent Past, Current & Future Analysis for
Life Science Tools by Technology – Cell Biology, Genomics,
Proteomics and Other Technologies – Independent Analysis of
Annual Revenues in US$ Million for the Years 2022 through 2030
and % CAGR
Table 36: Canada Historic Review for Life Science Tools by
Technology – Cell Biology, Genomics, Proteomics and Other
Technologies Markets – Independent Analysis of Annual Revenues
in US$ Million for Years 2014 through 2021 and % CAGR
Table 37: Canada 16-Year Perspective for Life Science Tools by
Technology – Percentage Breakdown of Value Revenues for Cell
Biology, Genomics, Proteomics and Other Technologies for the
Years 2014, 2023 & 2030
Table 38: Canada Recent Past, Current & Future Analysis for
Life Science Tools by End-Use – Healthcare, Biopharmaceutical
Companies, Government & Academics and Other End-Uses –
Independent Analysis of Annual Revenues in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 39: Canada Historic Review for Life Science Tools by
End-Use – Healthcare, Biopharmaceutical Companies, Government &
Academics and Other End-Uses Markets – Independent Analysis of
Annual Revenues in US$ Million for Years 2014 through 2021 and
% CAGR
Table 40: Canada 16-Year Perspective for Life Science Tools by
End-Use – Percentage Breakdown of Value Revenues for
Healthcare, Biopharmaceutical Companies, Government & Academics
and Other End-Uses for the Years 2014, 2023 & 2030
JAPAN
Life Science Tools Market Presence – Strong/Active/Niche/
Trivial – Key Competitors in Japan for 2023 (E)
Market Analytics
Table 41: Japan Recent Past, Current & Future Analysis for Life
Science Tools by Technology – Cell Biology, Genomics,
Proteomics and Other Technologies – Independent Analysis of
Annual Revenues in US$ Million for the Years 2022 through 2030
and % CAGR
Table 42: Japan Historic Review for Life Science Tools by
Technology – Cell Biology, Genomics, Proteomics and Other
Technologies Markets – Independent Analysis of Annual Revenues
in US$ Million for Years 2014 through 2021 and % CAGR
Table 43: Japan 16-Year Perspective for Life Science Tools by
Technology – Percentage Breakdown of Value Revenues for Cell
Biology, Genomics, Proteomics and Other Technologies for the
Years 2014, 2023 & 2030
Table 44: Japan Recent Past, Current & Future Analysis for Life
Science Tools by End-Use – Healthcare, Biopharmaceutical
Companies, Government & Academics and Other End-Uses –
Independent Analysis of Annual Revenues in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 45: Japan Historic Review for Life Science Tools by
End-Use – Healthcare, Biopharmaceutical Companies, Government &
Academics and Other End-Uses Markets – Independent Analysis of
Annual Revenues in US$ Million for Years 2014 through 2021 and
% CAGR
Table 46: Japan 16-Year Perspective for Life Science Tools by
End-Use – Percentage Breakdown of Value Revenues for
Healthcare, Biopharmaceutical Companies, Government & Academics
and Other End-Uses for the Years 2014, 2023 & 2030
CHINA
Life Science Tools Market Presence – Strong/Active/Niche/
Trivial – Key Competitors in China for 2023 (E)
Market Analytics
Table 47: China Recent Past, Current & Future Analysis for Life
Science Tools by Technology – Cell Biology, Genomics,
Proteomics and Other Technologies – Independent Analysis of
Annual Revenues in US$ Million for the Years 2022 through 2030
and % CAGR
Table 48: China Historic Review for Life Science Tools by
Technology – Cell Biology, Genomics, Proteomics and Other
Technologies Markets – Independent Analysis of Annual Revenues
in US$ Million for Years 2014 through 2021 and % CAGR
Table 49: China 16-Year Perspective for Life Science Tools by
Technology – Percentage Breakdown of Value Revenues for Cell
Biology, Genomics, Proteomics and Other Technologies for the
Years 2014, 2023 & 2030
Table 50: China Recent Past, Current & Future Analysis for Life
Science Tools by End-Use – Healthcare, Biopharmaceutical
Companies, Government & Academics and Other End-Uses –
Independent Analysis of Annual Revenues in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 51: China Historic Review for Life Science Tools by
End-Use – Healthcare, Biopharmaceutical Companies, Government &
Academics and Other End-Uses Markets – Independent Analysis of
Annual Revenues in US$ Million for Years 2014 through 2021 and
% CAGR
Table 52: China 16-Year Perspective for Life Science Tools by
End-Use – Percentage Breakdown of Value Revenues for
Healthcare, Biopharmaceutical Companies, Government & Academics
and Other End-Uses for the Years 2014, 2023 & 2030
EUROPE
Table 53: Europe Recent Past, Current & Future Analysis for
Life Science Tools by Geographic Region – France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets –
Independent Analysis of Annual Revenues in US$ Million for
Years 2022 through 2030 and % CAGR
Table 54: Europe Historic Review for Life Science Tools by
Geographic Region – France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets – Independent Analysis of Annual
Revenues in US$ Million for Years 2014 through 2021 and % CAGR
Table 55: Europe 16-Year Perspective for Life Science Tools by
Geographic Region – Percentage Breakdown of Value Revenues for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2014, 2023 & 2030
Table 56: Europe Recent Past, Current & Future Analysis for
Life Science Tools by Technology – Cell Biology, Genomics,
Proteomics and Other Technologies – Independent Analysis of
Annual Revenues in US$ Million for the Years 2022 through 2030
and % CAGR
Table 57: Europe Historic Review for Life Science Tools by
Technology – Cell Biology, Genomics, Proteomics and Other
Technologies Markets – Independent Analysis of Annual Revenues
in US$ Million for Years 2014 through 2021 and % CAGR
Table 58: Europe 16-Year Perspective for Life Science Tools by
Technology – Percentage Breakdown of Value Revenues for Cell
Biology, Genomics, Proteomics and Other Technologies for the
Years 2014, 2023 & 2030
Table 59: Europe Recent Past, Current & Future Analysis for
Life Science Tools by End-Use – Healthcare, Biopharmaceutical
Companies, Government & Academics and Other End-Uses –
Independent Analysis of Annual Revenues in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 60: Europe Historic Review for Life Science Tools by
End-Use – Healthcare, Biopharmaceutical Companies, Government &
Academics and Other End-Uses Markets – Independent Analysis of
Annual Revenues in US$ Million for Years 2014 through 2021 and
% CAGR
Table 61: Europe 16-Year Perspective for Life Science Tools by
End-Use – Percentage Breakdown of Value Revenues for
Healthcare, Biopharmaceutical Companies, Government & Academics
and Other End-Uses for the Years 2014, 2023 & 2030
FRANCE
Table 62: France Recent Past, Current & Future Analysis for
Life Science Tools by Technology – Cell Biology, Genomics,
Proteomics and Other Technologies – Independent Analysis of
Annual Revenues in US$ Million for the Years 2022 through 2030
and % CAGR
Table 63: France Historic Review for Life Science Tools by
Technology – Cell Biology, Genomics, Proteomics and Other
Technologies Markets – Independent Analysis of Annual Revenues
in US$ Million for Years 2014 through 2021 and % CAGR
Table 64: France 16-Year Perspective for Life Science Tools by
Technology – Percentage Breakdown of Value Revenues for Cell
Biology, Genomics, Proteomics and Other Technologies for the
Years 2014, 2023 & 2030
Table 65: France Recent Past, Current & Future Analysis for
Life Science Tools by End-Use – Healthcare, Biopharmaceutical
Companies, Government & Academics and Other End-Uses –
Independent Analysis of Annual Revenues in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 66: France Historic Review for Life Science Tools by
End-Use – Healthcare, Biopharmaceutical Companies, Government &
Academics and Other End-Uses Markets – Independent Analysis of
Annual Revenues in US$ Million for Years 2014 through 2021 and
% CAGR
Table 67: France 16-Year Perspective for Life Science Tools by
End-Use – Percentage Breakdown of Value Revenues for
Healthcare, Biopharmaceutical Companies, Government & Academics
and Other End-Uses for the Years 2014, 2023 & 2030
GERMANY
Table 68: Germany Recent Past, Current & Future Analysis for
Life Science Tools by Technology – Cell Biology, Genomics,
Proteomics and Other Technologies – Independent Analysis of
Annual Revenues in US$ Million for the Years 2022 through 2030
and % CAGR
Table 69: Germany Historic Review for Life Science Tools by
Technology – Cell Biology, Genomics, Proteomics and Other
Technologies Markets – Independent Analysis of Annual Revenues
in US$ Million for Years 2014 through 2021 and % CAGR
Table 70: Germany 16-Year Perspective for Life Science Tools by
Technology – Percentage Breakdown of Value Revenues for Cell
Biology, Genomics, Proteomics and Other Technologies for the
Years 2014, 2023 & 2030
Table 71: Germany Recent Past, Current & Future Analysis for
Life Science Tools by End-Use – Healthcare, Biopharmaceutical
Companies, Government & Academics and Other End-Uses –
Independent Analysis of Annual Revenues in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 72: Germany Historic Review for Life Science Tools by
End-Use – Healthcare, Biopharmaceutical Companies, Government &
Academics and Other End-Uses Markets – Independent Analysis of
Annual Revenues in US$ Million for Years 2014 through 2021 and
% CAGR
Table 73: Germany 16-Year Perspective for Life Science Tools by
End-Use – Percentage Breakdown of Value Revenues for
Healthcare, Biopharmaceutical Companies, Government & Academics
and Other End-Uses for the Years 2014, 2023 & 2030
ITALY
Table 74: Italy Recent Past, Current & Future Analysis for Life
Science Tools by Technology – Cell Biology, Genomics,
Proteomics and Other Technologies – Independent Analysis of
Annual Revenues in US$ Million for the Years 2022 through 2030
and % CAGR
Table 75: Italy Historic Review for Life Science Tools by
Technology – Cell Biology, Genomics, Proteomics and Other
Technologies Markets – Independent Analysis of Annual Revenues
in US$ Million for Years 2014 through 2021 and % CAGR
Table 76: Italy 16-Year Perspective for Life Science Tools by
Technology – Percentage Breakdown of Value Revenues for Cell
Biology, Genomics, Proteomics and Other Technologies for the
Years 2014, 2023 & 2030
Table 77: Italy Recent Past, Current & Future Analysis for Life
Science Tools by End-Use – Healthcare, Biopharmaceutical
Companies, Government & Academics and Other End-Uses –
Independent Analysis of Annual Revenues in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 78: Italy Historic Review for Life Science Tools by
End-Use – Healthcare, Biopharmaceutical Companies, Government &
Academics and Other End-Uses Markets – Independent Analysis of
Annual Revenues in US$ Million for Years 2014 through 2021 and
% CAGR
Table 79: Italy 16-Year Perspective for Life Science Tools by
End-Use – Percentage Breakdown of Value Revenues for
Healthcare, Biopharmaceutical Companies, Government & Academics
and Other End-Uses for the Years 2014, 2023 & 2030
UNITED KINGDOM
Table 80: UK Recent Past, Current & Future Analysis for Life
Science Tools by Technology – Cell Biology, Genomics,
Proteomics and Other Technologies – Independent Analysis of
Annual Revenues in US$ Million for the Years 2022 through 2030
and % CAGR
Table 81: UK Historic Review for Life Science Tools by
Technology – Cell Biology, Genomics, Proteomics and Other
Technologies Markets – Independent Analysis of Annual Revenues
in US$ Million for Years 2014 through 2021 and % CAGR
Table 82: UK 16-Year Perspective for Life Science Tools by
Technology – Percentage Breakdown of Value Revenues for Cell
Biology, Genomics, Proteomics and Other Technologies for the
Years 2014, 2023 & 2030
Table 83: UK Recent Past, Current & Future Analysis for Life
Science Tools by End-Use – Healthcare, Biopharmaceutical
Companies, Government & Academics and Other End-Uses –
Independent Analysis of Annual Revenues in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 84: UK Historic Review for Life Science Tools by End-Use –
Healthcare, Biopharmaceutical Companies, Government &
Academics and Other End-Uses Markets – Independent Analysis of
Annual Revenues in US$ Million for Years 2014 through 2021 and
% CAGR
Table 85: UK 16-Year Perspective for Life Science Tools by
End-Use – Percentage Breakdown of Value Revenues for
Healthcare, Biopharmaceutical Companies, Government & Academics
and Other End-Uses for the Years 2014, 2023 & 2030
SPAIN
Table 86: Spain Recent Past, Current & Future Analysis for Life
Science Tools by Technology – Cell Biology, Genomics,
Proteomics and Other Technologies – Independent Analysis of
Annual Revenues in US$ Million for the Years 2022 through 2030
and % CAGR
Table 87: Spain Historic Review for Life Science Tools by
Technology – Cell Biology, Genomics, Proteomics and Other
Technologies Markets – Independent Analysis of Annual Revenues
in US$ Million for Years 2014 through 2021 and % CAGR
Table 88: Spain 16-Year Perspective for Life Science Tools by
Technology – Percentage Breakdown of Value Revenues for Cell
Biology, Genomics, Proteomics and Other Technologies for the
Years 2014, 2023 & 2030
Table 89: Spain Recent Past, Current & Future Analysis for Life
Science Tools by End-Use – Healthcare, Biopharmaceutical
Companies, Government & Academics and Other End-Uses –
Independent Analysis of Annual Revenues in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 90: Spain Historic Review for Life Science Tools by
End-Use – Healthcare, Biopharmaceutical Companies, Government &
Academics and Other End-Uses Markets – Independent Analysis of
Annual Revenues in US$ Million for Years 2014 through 2021 and
% CAGR
Table 91: Spain 16-Year Perspective for Life Science Tools by
End-Use – Percentage Breakdown of Value Revenues for
Healthcare, Biopharmaceutical Companies, Government & Academics
and Other End-Uses for the Years 2014, 2023 & 2030
RUSSIA
Table 92: Russia Recent Past, Current & Future Analysis for
Life Science Tools by Technology – Cell Biology, Genomics,
Proteomics and Other Technologies – Independent Analysis of
Annual Revenues in US$ Million for the Years 2022 through 2030
and % CAGR
Table 93: Russia Historic Review for Life Science Tools by
Technology – Cell Biology, Genomics, Proteomics and Other
Technologies Markets – Independent Analysis of Annual Revenues
in US$ Million for Years 2014 through 2021 and % CAGR
Table 94: Russia 16-Year Perspective for Life Science Tools by
Technology – Percentage Breakdown of Value Revenues for Cell
Biology, Genomics, Proteomics and Other Technologies for the
Years 2014, 2023 & 2030
Table 95: Russia Recent Past, Current & Future Analysis for
Life Science Tools by End-Use – Healthcare, Biopharmaceutical
Companies, Government & Academics and Other End-Uses –
Independent Analysis of Annual Revenues in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 96: Russia Historic Review for Life Science Tools by
End-Use – Healthcare, Biopharmaceutical Companies, Government &
Academics and Other End-Uses Markets – Independent Analysis of
Annual Revenues in US$ Million for Years 2014 through 2021 and
% CAGR
Table 97: Russia 16-Year Perspective for Life Science Tools by
End-Use – Percentage Breakdown of Value Revenues for
Healthcare, Biopharmaceutical Companies, Government & Academics
and Other End-Uses for the Years 2014, 2023 & 2030
REST OF EUROPE
Table 98: Rest of Europe Recent Past, Current & Future Analysis
for Life Science Tools by Technology – Cell Biology, Genomics,
Proteomics and Other Technologies – Independent Analysis of
Annual Revenues in US$ Million for the Years 2022 through 2030
and % CAGR
Table 99: Rest of Europe Historic Review for Life Science Tools
by Technology – Cell Biology, Genomics, Proteomics and Other
Technologies Markets – Independent Analysis of Annual Revenues
in US$ Million for Years 2014 through 2021 and % CAGR
Table 100: Rest of Europe 16-Year Perspective for Life Science
Tools by Technology – Percentage Breakdown of Value Revenues
for Cell Biology, Genomics, Proteomics and Other Technologies
for the Years 2014, 2023 & 2030
Table 101: Rest of Europe Recent Past, Current & Future
Analysis for Life Science Tools by End-Use – Healthcare,
Biopharmaceutical Companies, Government & Academics and Other
End-Uses – Independent Analysis of Annual Revenues in US$
Million for the Years 2022 through 2030 and % CAGR
Table 102: Rest of Europe Historic Review for Life Science
Tools by End-Use – Healthcare, Biopharmaceutical Companies,
Government & Academics and Other End-Uses Markets – Independent
Analysis of Annual Revenues in US$ Million for Years 2014
through 2021 and % CAGR
Table 103: Rest of Europe 16-Year Perspective for Life Science
Tools by End-Use – Percentage Breakdown of Value Revenues for
Healthcare, Biopharmaceutical Companies, Government & Academics
and Other End-Uses for the Years 2014, 2023 & 2030
ASIA-PACIFIC
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032055/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
